China SXT Pharmaceuticals Inc (SXTC) — Financial Flexibility Index
China SXT Pharmaceuticals Inc (SXTC) has a Financial Flexibility Index of -0.45x as of June 2026. Free cash flow of $-2.26 Million (operating CF $-2.26 Million minus capex $0.00) represents 0% of total liabilities ($5.05 Million). Check cash flow reinvestment rate of China SXT Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China SXT Pharmaceuticals Inc Financial Flexibility Index (2016–2026)
Historical Financial Flexibility Index trend for China SXT Pharmaceuticals Inc across 11 annual periods. For the full cash flow conversion analysis, see China SXT Pharmaceuticals Inc (SXTC) cash conversion ratio.
Annual Financial Flexibility Index for China SXT Pharmaceuticals Inc (2016–2026)
Year-by-year free cash flow to debt coverage for China SXT Pharmaceuticals Inc. Explore China SXT Pharmaceuticals Inc (SXTC) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -0.80x | $-4.02 Million | $-4.02 Million | $5.05 Million | ▼ -111.4% |
| 2025 | -0.38x | $-2.34 Million | $-2.35 Million | $6.22 Million | ▼ -80.3% |
| 2024 | -0.21x | $-1.92 Million | $-1.93 Million | $9.20 Million | ▼ -30720.4% |
| 2023 | 0.00x | $-10.07K | $-80.76K | $14.86 Million | ▲ +99.5% |
| 2022 | -0.14x | $-2.31 Million | $-2.37 Million | $17.12 Million | ▼ -105.1% |
| 2021 | -0.07x | $-1.22 Million | $-1.32 Million | $18.59 Million | ▼ -160.4% |
| 2020 | 0.11x | $1.34 Million | $934.25K | $12.30 Million | ▼ -18.3% |
| 2019 | 0.13x | $849.28K | $239.19K | $6.36 Million | ▼ -80.4% |
| 2018 | 0.68x | $2.97 Million | $1.92 Million | $4.37 Million | ▲ +407.3% |
| 2017 | 0.13x | $479.35K | $293.04K | $3.58 Million | ▲ +166.2% |
| 2016 | 0.05x | $279.46K | $182.47K | $5.55 Million | — |